Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2012
10/10/2012CN101073584B Method and compositions for altering cell function
10/09/2012US8283380 Methods for treatment of parkinson's disease
10/09/2012US8283330 Modulators of pharmacological agents
10/09/2012US8283313 Methods of increasing platelet and hematopoietic stem cell production
10/09/2012US8283135 Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
10/09/2012US8282930 Molecular delivery vehicle
10/09/2012US8282920 Phage therapy against Pseudomonas aeruginosa
10/09/2012US8282913 Ion binding polymers and uses thereof
10/09/2012CA2674542C Neuroprotection by blood flow stabilization
10/09/2012CA2556944C Thiazole derivative
10/09/2012CA2537355C Condensed ring compound and use thereof
10/09/2012CA2533845C Pharmaceutical compositions comprising insulin sensitivity enhancer and another antidiabetic
10/09/2012CA2476594C Mono-and bicyclic azole derivatives that inhibit the interaction of ligands with rage
10/09/2012CA2448622C Proliposomal drug delivery system
10/09/2012CA2358517C Method and composition for angiogenesis inhibition
10/04/2012WO2012135095A2 S1p antagonists as adjunct ocular hypotensives
10/04/2012WO2012133914A1 Potentiator of cancer immunity containing rankl antagonist
10/04/2012WO2012133825A1 Hot flash suppressant
10/04/2012WO2012133693A1 Pharmaceutical combination for diabetes treatment
10/04/2012WO2012132335A1 Method for manufacturing culture medium, and culture medium manufactured by method
10/04/2012WO2012132141A1 Composition for delivering drug into cell and method therefor
10/04/2012WO2012130862A1 Selection of hcv treatment
10/04/2012WO2012130698A1 Composition comprising a diindolylmethane and a retinoid to treat a skin condition
10/04/2012WO2012130646A1 N-acetyl-l-cysteine for the treatment of dysmenorrhea
10/04/2012WO2012130627A1 Nutritional compositions for increasing arginine levels and methods of using same
10/04/2012WO2012130609A1 New combination comprising n-acetyl-l-cysteine and its use
10/04/2012WO2012130336A1 Delivery of large molecular weight biologically active substances
10/04/2012WO2012129759A1 Oral dosage formulations containing both immediate-release and sustained-release drugs for treating neurodegenerative disorders
10/04/2012WO2012107416A3 Improved immunotherapy
10/04/2012WO2012065019A3 Combination comprising pyridopyrimidinone inhibitors of pi3k alpha
10/04/2012US20120253219 Methods for Recommending Neurophysiological Disorder Therapy
10/04/2012US20120252886 Catechins for the treatment of amyloidosis
10/04/2012US20120252832 Abuse-resistant controlled-release opioid dosage form
10/04/2012US20120252794 Analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor
10/04/2012US20120252790 Amino-Derivatives As Novel Inhibitors Of Histone Deacetylase
10/04/2012US20120252097 Therapeutic Agents Comprising Pro-Apoptotic Proteins
10/04/2012US20120251590 Controlled release formulations of opioid and nonopioid analgesics
10/04/2012CA2831290A1 S1p antagonists as adjunct ocular hypotensives
10/04/2012CA2831247A1 Cancer immunopotentiating agent containing rankl antagonist
10/04/2012CA2831185A1 Composition comprising a diindolylmethane and a retinoid to treat a skin condition
10/04/2012CA2830112A1 Selection of hcv treatment
10/04/2012CA2829229A1 Nutritional compositions for increasing arginine levels and methods of using same
10/03/2012EP2506008A1 Method for screening drug efficacious in treating dry eye and/or keratoconjunctival disorders and pharmaceutical composition obtained thereby
10/03/2012EP2505660A1 Method for screening of therapeutic agent for hyperlipemia
10/03/2012EP2504011A2 Methods for treating mild cognitive impairment
10/03/2012EP2504010A1 Fused bicyclic pyrimidine derivatives and methods of use thereof
10/03/2012EP2504006A1 Compositions comprising amino acids for treating chronic obstructive pulmonary disease
10/03/2012EP2504004A1 Pharmaceutical compositions and therapeutic applications of a hydrocortisone derivative designated as deina
10/03/2012EP2504002A1 Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
10/03/2012EP2504001A1 Combination for the treatment of radiation - or chemotherapy - induced mucositis
10/03/2012EP2503999A1 Pharmaceutical composition comprising propofol
10/03/2012CN1638787B Helicobacter pylori adhesion inhibitor
10/03/2012CN102711832A Composition for controlling weight gain and food product containing same
10/03/2012CN102711756A Pharmaceutical for preventing or treating disorders accompanied by ocular angiogenesis and/or elevated ocular vascular permeability
10/03/2012CN102711746A Pharmaceutical composition for treating alcohol dependency
10/03/2012CN102711742A Topical pharmaceutical preparations having both a nanoparticle solution and a nanoparticle suspension and methods for the treatment of acute and chronic pain therewith
10/03/2012CN102711513A Compositions including pyruvate for companion animals and methods of use thereof
10/03/2012CN102703060A Targeted tracing noble metal fluorescence probe and anti-tumor prodrug
10/03/2012CN102702454A PH response four-arm star block copolymer and preparation method and application thereof
10/03/2012CN102702453A pH-responsive 6-arm star block copolymer and preparation method and application thereof
10/03/2012CN102698276A Bitherapy and tritherapy used for treating an hiv-positive patient
10/03/2012CN102698275A Application of myricetin similar flavonol compound to preparation of antitumor medicament
10/03/2012CN102698274A Medicine composition for treating intractable escherichia coli of fowls
10/03/2012CN102698273A Formulations and treatments for trichology
10/03/2012CN102698272A Medicinal composition for preventing diabetes, and application thereof
10/03/2012CN102698271A Hypoglycemic drug composition and application of hypoglycemic drug composition
10/03/2012CN102698270A Method for enhancing therapeutic agent uptake by target cell and pharmaceutical composition
10/03/2012CN102698265A Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy
10/03/2012CN102698261A Use of panton-valentine leukocidin for treating and preventing staphylococcus infections
10/03/2012CN102698116A Application of lophatherum gracile total flavonoids in preparation of medicine and functional food for preventing and treating myocardial ischemia disease
10/03/2012CN102697768A Application of luteolin flavonoid compounds in preparation of anti-tumor medicaments
10/03/2012CN102697737A Tumor-targeting drug-loaded particles
10/03/2012CN102697735A Polymer nanoparticles for loading alkaline antitumor drugs
10/03/2012CN102697726A Liposome combined medicament of alprostadil and like and large-scale industrial production technology and application thereof
10/03/2012CN102697704A Controlled release formulations of opioid and nonopioid analgesics
10/03/2012CN102266561B Application of Wnt/beta-catenin signal channel inhibitor to preparation of medicament for promoting apoptosis
10/03/2012CN102139107B Anticancer effect of antagonist of neurokinin receptor
10/03/2012CN101516375B Combinations of class-I specific histone deacetylase inhibitors with proteasome inhibitors
10/03/2012CN101466386B Augmentation of titer for vaccination in animals
10/03/2012CN101257899B Application of alkamine compound in the preparation of drugs of autoimmune diseases
10/03/2012CN101222912B Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
10/03/2012CN101067135B Novel oligonucleotides and use of oligonucleotides modulating the expression of enzymes involved in the synthesis of melanic pigments, as depigmentation agents
10/02/2012US8278422 Antibodies that specifically bind beta-like glycoprotein hormone polypeptides and heterodimers thereof
10/02/2012US8278339 Valsartan salts
10/02/2012US8278286 Use of gp130 activators in diabetic neuropathy
10/02/2012US8278268 Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators
10/02/2012US8278098 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
10/02/2012US8277847 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy
10/02/2012US8277846 Complexing agents for compositions containing inclusion complexes
10/02/2012US8277823 Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids
10/02/2012US8277815 Pharmaceutical composition comprising an antigen
10/02/2012US8277802 Diagnosis and prevention of cancer cell invasion
10/02/2012US8277782 Antiinflammatory agent, metalloproteinase inhibitor, anti-oxidant and modifier of cell redox status, vitamins, inhibitor of activation of nuclear factor kappa beta
10/02/2012US8277372 Cardiac support device with differential compliance
10/02/2012CA2669457C Calcium-containing structures and methods of making and using the same
10/02/2012CA2550841C Novel combination of anticholinergic and .beta. mimetics for the treatment of respiratory diseases
10/02/2012CA2532415C Antiglucocorticoid therapy for the prevention of neurological damage in premature infants
10/02/2012CA2526636C Diaryl ureas for diseases mediated by pdgfr
10/02/2012CA2520172C Novel methods for the treatment of cancer with an indoleamine 2, 3-dioxygenase inhibitor
10/02/2012CA2502848C Use of irl-1620 and paclitaxel for preventing and treating breast tumors
1 ... 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 ... 1151